| Literature DB >> 28679369 |
Katrien Vanthomme1, Hadewijch Vandenheede2, Paulien Hagedoorn2, Sylvie Gadeyne2.
Abstract
BACKGROUND: According to the "fundamental cause" theory, emerging knowledge on health-enhancing behaviours and technologies results in health disparities. This study aims to assess (trends in) educational inequalities in site-specific cancer mortality in Belgian men in the 1990s and the 2000s using this framework.Entities:
Keywords: Cancer; Fundamental cause theory; Mortality; Socioeconomic inequality
Mesh:
Year: 2017 PMID: 28679369 PMCID: PMC5498997 DOI: 10.1186/s12885-017-3461-8
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
International Classification of Diseases (ICD-) codes for the cancer sites included in the analysis (9th and 10th revision) and level of preventability
| ICD-9 | ICD-10 | Behavioural change | Medical interventions | |
|---|---|---|---|---|
| Malignant neoplasms of: | ||||
| Head and neck | 140–149, 160–161 | C00-C14, C30-C32 | Yes | No |
| Oesophagus | 150 | C15 | Yes | No |
| Stomach | 151 | C16 | Yes | No |
| Colorectum and anus | 153–154 | C18-C21 | No | Yes |
| Liver | 155 | C22 | Yes | No |
| Pancreas | 157 | C25 | No | No |
| Lung, bronchus and trachea | 162 | C33-C34 | Yes | No |
| Prostate | 185 | C61 | No | Yes |
| Kidney | 189 | C64-C66, C68 | No | No |
| Bladder | 188 | C67 | No | Yes |
| Eye, brain and central nervous system | 190–192 | C69-C72 | No | No |
| Malignant melanoma | 172–173 | C43-C44 | No | Yes |
| Non-Hodgkin Lymphoma | 200, 202 | C82-C85 | No | No |
| Multiple myeloma | 203 | C90 | No | No |
| Leukaemia | 204–208 | C91-C95 | No | No |
Descriptive statistics for the Belgian male study population aged 50–79 years for the periods 1991–1997 and 2001–2008
| 1991–1997 | 2001–2008 | |
|---|---|---|
| Number of men aged 50–79 years during follow-up | 1,714,999 | 1,967,404 |
| Percentage of the total male population aged 50–79 years during follow-up | 35.17% | 39.28% |
| Person-years | 9,048,137 | 10,362,159 |
| Number of cancer deaths | 76,117 | 70,181 |
| Distribution of education (%) | ||
| Lower secondary or less | 73.14 | 56.68 |
| Upper secondary | 15.26 | 21.92 |
| Tertiary education | 10.65 | 21.40 |
Source: censuses of 1991 and 2001 linked to Population and Mortality Register Data for the periods 1991–1997 and 2001–2008
Absolute and relative educational inequalities in site-specific cancer mortality among Belgian men aged 50–79 years for the period 2001–2008
| Cancer site | Total population | Low educated c | Mid educated d | High educated e | MRD f,g (95% CI h) | |
|---|---|---|---|---|---|---|
| Total cancer mortality | ASMR a | 687.0 (682.0–692.1) | 729.8 (722.8–736.8) | 612.6 (600.5–624.6) | 491.4 (480.1–502.7) | 238.4 (234.1–242.7) |
| MRR b | 1.55 (1.52–1.59) | 1.29 (1.25–1.33) | 1.00 | |||
| Head and neck | ASMR | 30.7 (29.6–31.7) | 33.4 (31.8–34.9) | 26.4 (24.0–28.8) | 18.7 (16.6–20.7) | 14.7 (14.2–15.2) |
| MRR | 1.95 (1.74–2.19) | 1.50 (1.31–1.72) | 1.00 | |||
| Oesophagus | ASMR | 24.6 (23.6–25.5) | 24.9 (23.6–26.2) | 25.1 (22.7–27.5) | 21.4 (19.1–23.7) | 3.5 (2.5–4.5) |
| MRR | 1.26 (1.12–1.42) | 1.24 (1.08–1.43) | 1.00 | |||
| Stomach | ASMR | 22.0 (21.1–22.9) | 23.8 (22.5–25.0) | 17.2 (15.1–19.2) | 16.1 (14.0–18.1) | 7.7 (6.9–8.5) |
| MRR | 1.50 (1.31–1.72) | 1.09 (0.92–1.29) | 1.00 | |||
| Colorectal | ASMR | 65.9 (64.3–67.4) | 66.2 (64.1–68.3) | 63.2 (59.3–67.1) | 52.4 (50.4–58.0) | 13.8 (10.3–13.7) |
| MRR | 1.25 (1.16–1.34) | 1.19 (1.09–1.30) | 1.00 | |||
| Liver | ASMR | 19.5 (18.6–20.3) | 18.8 (17.7–20.0) | 20.7 (18.5–22.9) | 18.9 (16.7–21.2) | −0.1 (−1.2–1.0) |
| MRR | 1.10 (0.96–1.25) | 1.20 (1.03–1.41) | 1.00 | |||
| Pancreas | ASMR | 33.2 (32.0–34.3) | 33.8 (32.3–35.3) | 31.3 (28.5–34.0) | 33.5 (30.5–36.5) | 0.3 (−1.2–1.8) |
| MRR | 1.07 (0.97–1.18) | 0.98 (0.87–1.11) | 1.00 | |||
| Lung and trachea | ASMR | 252.9 (249.9–256.0) | 286.1 (281.7–290.5) | 196.7 (189.9–203.6) | 134.4 (128.5–140.3) | 151.7 (150.2–153.2) |
| MRR | 2.23 (2.13–2.33) | 1.52 (1.44–1.60) | 1.00 | |||
| Melanoma | ASMR | 6.0 (5.5–6.5) | 5.8 (5.2–6.4) | 7.0 (5.8–8.3) | 6.4 (5.2–7.7) | −0.6 (−1.3–0.0) |
| MRR | 0.89 (0.72–1.11) | 1.05 (0.81–1.35) | 1.00 | |||
| Prostate | ASMR | 48.4 (47.0–49.7) | 47.7 (45.9–49.4) | 46.7 (43.2–50.2) | 43.7 (40.2–47.3) | 4.0 (2.1–5.7) |
| MRR | 1.11 (1.02–1.21) | 1.06 (0.95–1.18) | 1.00 | |||
| Kidney | ASMR | 18.9 (18.0–19.7) | 19.1 (18.0–20.2) | 20.1 (17.8–22.3) | 16.8 (14.7–18.9) | 2.3 (1.3–3.3) |
| MRR | 1.15 (1.00–1.31) | 1.17 (0.99–1.37) | 1.00 | |||
| Bladder | ASMR | 24.8 (23.8–25.8) | 25.3 (24.0–26.6) | 23.3 (20.8–25.7) | 17.8 (15.6–20.0) | 7.5 (6.6–8.4) |
| MRR | 1.49 (1.30–1.70) | 1.34 (1.14–1.57) | 1.00 | |||
| Eye, brain, central nervous system | ASMR | 14.9 (14.2–15.7) | 14.9 (13.9–15.9) | 14.8 (13.0–16.7) | 14.1 (12.3–15.9) | 0.8 (0.0–1.6) |
| MRR | 1.06 (0.92–1.22) | 1.04 (0.88–1.24) | 1.00 | |||
| Non-Hodgkin Lymphoma | ASMR | 14.4 (13.7–15.1) | 13.9 (13.0–14.9) | 15.9 (13.9–17.9) | 13.2 (11.3–15.1) | 0.7 (−0.2–1.7) |
| MRR | 1.09 (0.93–1.27) | 1.23 (1.02–1.47) | 1.00 | |||
| Multiple myeloma | ASMR | 9.8 (9.2–10.4) | 9.9 (9.1–10.7) | 10.8 (9.2–12.5) | 8.6 (7.1–10.1) | 1.3 (0.6–2.0) |
| MRR | 1.12 (0.93–1.35) | 1.20 (0.96–1.51) | 1.00 | |||
| Leukaemia | ASMR | 18.9 (18.1–19.8) | 18.8 (17.7–19.9) | 19.1 (16.9–21.3) | 17.2 (15.0–19.4) | 1.6 (0.5–2.7) |
| MRR | 1.14 (0.99–1.31) | 1.12 (0.95–1.33) | 1.00 |
aAge-standardized mortality rate using the Belgian population at the moment of the 2001 census as reference; expressed per 100,000 men
bMortality Rate Ratio
cLow-educated persons have completed lower secondary education or less
dMid-educated persons have completed upper secondary education
eHigh-education persons have completed tertiary education
fMortality rate difference
gThe difference between the ASMR of the lowest educated and the ASMR of the highest educated
h95% Confidence Intervals
Trends between 1991 and 1997 and 2001–2008 in absolute and relative educational inequalities in site-specific cancer mortality among Belgian men aged 50–79 years
| Cancer site | Period | AMD a | PMD b | PAF c | RII d (95% CI) e |
|---|---|---|---|---|---|
| Total cancer mortality | 1991–1997 | 49.4 | −1.43 | 0.28 | 1.88 (1.81–1.95) |
| 2001–2011 | 0.28 | 1.92 (1.85–1.99) | |||
| Head and neck | 1991–1997 | 1.2 | −8.67 | 0.32 | 2.35 (1.99–2.78) |
| 2001–2011 | 0.39 | 2.63 (2.23–3.10) | |||
| Oesophagus | 1991–1997 | 0.3 | 2.38 | 0.14 | 1.34 (1.09–1.66) |
| 2001–2011 | 0.13 | 1.34 (1.13–1.59) | |||
| Stomach | 1991–1997 | 13.6 | 23.68 | 0.47 | 3.05 (2.50–3.73) |
| 2001–2011 | 0.27 | 2.03 (1.66–2.47) | |||
| Colorectal | 1991–1997 | −1.8 | −5.85 | 0.14 | 1.21 (1.08–1.36) |
| 2001–2011 | 0.20 | 1.24 (1.20–1.50) | |||
| Liver | 1991–1997 | −0.2 | −0.92 | −0.02 | 1.04 (0.82–1.30) |
| 2001–2011 | 0.03 | 1.06 (0.87–1.28) | |||
| Pancreas | 1991–1997 | −5.8 | −14.68 | −0.15 | 0.93 (0.78–1.10) |
| 2001–2011 | −0.01 | 1.15 (0.99–1.34) | |||
| Lung and trachea | 1991–1997 | 44.6 | −1.70 | 0.47 | 3.18 (2.98–3.39) |
| 2001–2011 | 0.47 | 3.34 (3.14–3.55) | |||
| Melanoma | 1991–1997 | −0.4 | −12.53 | −0.20 | 0.90 (0.57–1.41) |
| 2001–2011 | −0.07 | 0.79 (0.57–1.09) | |||
| Prostate | 1991–1997 | 5.6 | 3.12 | 0.12 | 1.20 (1.06–1.36) |
| 2001–2011 | 0.10 | 1.17 (1.03–1.33) | |||
| Kidney | 1991–1997 | 1.5 | 7.88 | 0.19 | 1.12 (0.89–1.40) |
| 2001–2011 | 0.11 | 1.16 (0.95–1.42) | |||
| Bladder | 1991–1997 | 5.8 | 7.84 | 0.33 | 1.96 (1.62–2.38) |
| 2001–2011 | 0.28 | 1.70 (1.41–2.05) | |||
| Eye, brain, central nervous system | 1991–1997 | −3.2 | −10.70 | −0.10 | 0.91 (0.74–1.12) |
| 2001–2011 | 0.05 | 1.08 (0.87–1.34) | |||
| Non-Hodgkin Lymphoma | 1991–1997 | 0.3 | 0.48 | 0.07 | 0.97 (0.77–1.23) |
| 2001–2011 | 0.08 | 1.02 (0.81–1.27) | |||
| Multiple myeloma | 1991–1997 | 0.1 | −0.53 | 0.12 | 1.23 (0.90–1.68) |
| 2001–2011 | 0.12 | 1.08 (0.83–1.42) | |||
| Leukaemia | 1991–1997 | −0.9 | −4.69 | 0.03 | 1.10 (0.88–1.37) |
| 2001–2011 | 0.09 | 1.18 (0.96–1.44) |
aAbsolute Mortality Decline: Difference between low and high educated in absolute mortality decline: (ASMR1990low - ASMR2000low) - (ASMR1990high - ASMR2000high)
bProportional Mortality Decline (in % points): Difference between low and high educated in proportional mortality decline: 100* (ASMR1990low - ASMR2000low)/ASMR1990low - 100*(ASMR1990high - ASMR2000high)/ASMR1990high
cPopulation Attributable Fraction of education for mortality: (ASMRtot - ASMRhigh)/ASMRtot
dRelative Index of Inequality
e95% Confidence Intervals